牛牛AI助理已提取核心訊息
In8bio, Inc. (INAB) has reported a transaction involving Trishna Goswami, the company's Chief Medical Officer. The transaction took place on February 7, 2024. However, the specific details regarding the number of shares, nature of shares, transaction price, and the total value of shares involved in the transaction were not disclosed in the announcement. This information is critical for investors to understand the potential impact on their investment and the confidence level of the company's insiders in the firm's prospects.
In8bio, Inc. (INAB) has reported a transaction involving Trishna Goswami, the company's Chief Medical Officer. The transaction took place on February 7, 2024. However, the specific details regarding the number of shares, nature of shares, transaction price, and the total value of shares involved in the transaction were not disclosed in the announcement. This information is critical for investors to understand the potential impact on their investment and the confidence level of the company's insiders in the firm's prospects.
In8Bio, Inc.（INAB）報告了一筆涉及該公司首席醫療官特里希納·戈斯瓦米的交易。該交易於 2024 年 2 月 7 日進行。但是，公告中沒有披露有關股票數量、股票性質、交易價格和交易所涉股票總價值的具體細節。這些信息對於投資者了解其投資的潛在影響以及公司內部人士對公司前景的信心水平至關重要。
In8Bio, Inc.（INAB）報告了一筆涉及該公司首席醫療官特里希納·戈斯瓦米的交易。該交易於 2024 年 2 月 7 日進行。但是，公告中沒有披露有關股票數量、股票性質、交易價格和交易所涉股票總價值的具體細節。這些信息對於投資者了解其投資的潛在影響以及公司內部人士對公司前景的信心水平至關重要。
有用
沒用